Revelation Biosciences Valuation
| REVBW Stock | USD 0.01 0 16.50% |
Revelation Biosciences seems to be overvalued based on Macroaxis valuation methodology. Our model determines the value of Revelation Biosciences from analyzing the company fundamentals such as EBITDA of (95.21 K), return on equity of -2.7, and Cash And Equivalents of 4.14 M as well as examining its technical indicators and probability of bankruptcy.
Overvalued
Today
Please note that Revelation Biosciences' price fluctuation is out of control at this time. Calculation of the real value of Revelation Biosciences is based on 3 months time horizon. Increasing Revelation Biosciences' time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
The fair value of the Revelation stock is determined by what a typical buyer is willing to pay for full or partial control of Revelation Biosciences. Since Revelation Biosciences is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Revelation Stock. However, Revelation Biosciences' intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 0.012 | Real 0.0101 | Hype 0.01 |
The intrinsic value of Revelation Biosciences' stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence Revelation Biosciences' stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
Estimating the potential upside or downside of Revelation Biosciences helps investors to forecast how Revelation stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Revelation Biosciences more accurately as focusing exclusively on Revelation Biosciences' fundamentals will not take into account other important factors: Traditionally, analysts and sophisticated investors use multiple methods for valuing a cash-flow-generating entity or its stock. For example, some money managers use Revelation Biosciences' intrinsic value based on its ongoing forecasts of Revelation Biosciences' financial statements. In contrast, other private, professional wealth advisors use a multiplier approach by looking to relative value analysis against Revelation Biosciences' closest peers.
Revelation Biosciences Cash |
|
Revelation Valuation Trend
Analysing the historical paterns of Revelation Biosciences' enterprise value and its market capitalization is a good way to estimate and gauge the value of Revelation Biosciences over time and is usually enough for investors to make rational market timing decisions.
Revelation Biosciences Total Value Analysis
Revelation Biosciences is at this time forecasted to have takeover price of 0 with market capitalization of 0, debt of 5.56 M, and cash on hands of 4.14 M. Please note that takeover price may be misleading and is a subject to mistakes in financial statements. We encourage investors to thoroughly investigate all of the Revelation Biosciences fundamentals before making investing decisions based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
0 | 0 | 5.56 M | 4.14 M |
Revelation Biosciences Asset Utilization
One of the ways to look at asset utilization of Revelation is to check how much profit was generated for every dollar of assets it reports. Revelation Biosciences holds a negative application of assets of -0.51 pct., losing $0.005098 for each dollar of assets held by the company. Inadequate asset utilization implies the company is being less effective with each dollar of assets it holds. Put it differently, asset utilization of Revelation Biosciences shows how discouraging it operates for each dollar spent on its assets.Revelation Biosciences Profitability Analysis
Net Loss for the year was (120.25 K) with profit before overhead, payroll, taxes, and interest of 0.About Revelation Biosciences Valuation
Our relative valuation model uses a comparative analysis of Revelation Biosciences. We calculate exposure to Revelation Biosciences's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Revelation Biosciences's related companies.| Last Reported | Projected for Next Year | ||
| Gross Profit | -25 K | -26.3 K |
Revelation Biosciences Growth Indicators
Investing in growth stocks can be very risky. If the company such as Revelation Biosciences does not do well, investors take a loss on the stock when it is time to sell. Also, because growth stocks typically do not pay dividends, the only opportunity an investor has to make money on their investment is when they eventually sell their shares.
| Common Stock Shares Outstanding | 228.6 K |
Revelation Biosciences Current Valuation Indicators
Valuation refers to the process of determining the present value of Revelation Biosciences and all of its assets. It can be calculated using a number of techniques. As many analysts who try to value Revelation we look at many different elements of the entity such as Revelation's management, its prospective future earnings, the current market value of the company's assets, as well as its capital structure formation.
Valuations are an essential part of business, for companies themselves, but also for investors. For companies, such as Revelation Biosciences, valuations can help measure their progress and success and can help them track their performance in the market compared to others. In addition, investors can use Revelation Biosciences' valuations to help determine the worth of potential investments. They can do this by using data and information made public by a company. Regardless of who the valuation is for, it essentially describes Revelation Biosciences' worth.Additional Tools for Revelation Stock Analysis
When running Revelation Biosciences' price analysis, check to measure Revelation Biosciences' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Revelation Biosciences is operating at the current time. Most of Revelation Biosciences' value examination focuses on studying past and present price action to predict the probability of Revelation Biosciences' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Revelation Biosciences' price. Additionally, you may evaluate how the addition of Revelation Biosciences to your portfolios can decrease your overall portfolio volatility.